Literature DB >> 21274350

Neuroleptic malignant syndrome after exposure to asenapine: a case report.

Niku Singh, Thomas N Wise.   

Abstract

Entities:  

Year:  2010        PMID: 21274350      PMCID: PMC3026005          DOI: 10.4088/PCC.10l00966yel

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


× No keyword cloud information.
  3 in total

Review 1.  Neuroleptic malignant syndrome.

Authors:  Jeffrey R Strawn; Paul E Keck; Stanley N Caroff
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

2.  Asenapine.

Authors:  Herbert Y Meltzer; Argyris Dritselis; Uma Yasothan; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

Review 3.  Asenapine.

Authors:  Juliane Weber; Paul L McCormack
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

  3 in total
  1 in total

1.  Neuroleptic malignant syndrome associated with quetiapine and venlafaxine use: a case report and discussion.

Authors:  Gary Woods; Catherine Taggart; Robert Boggs; Ian Cadden
Journal:  Ther Adv Psychopharmacol       Date:  2013-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.